Erdheim-Chester disease and vemurafenib: a review of ophthalmic presentations and clinical outcomes.

Park JK, Huang LC, Kossler AL

DOI: 10.1080/01676830.2022.2087232
Published: 2023 Jun
Container: Orbit (Amsterdam, Netherlands)
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/01676830.2022.2087232,
  title = {Erdheim-Chester disease and vemurafenib: a review of ophthalmic presentations and clinical outcomes.},
  author = {Park JK and Huang LC and Kossler AL},
  year = {2023},
  journal = {Orbit (Amsterdam, Netherlands)},
  doi = {10.1080/01676830.2022.2087232},
  url = {https://doi.org/10.1080/01676830.2022.2087232}
}

RIS

TY  - JOUR
TI  - Erdheim-Chester disease and vemurafenib: a review of ophthalmic presentations and clinical outcomes.
AU  - Park JK
AU  - Huang LC
AU  - Kossler AL
PY  - 2023
JO  - Orbit (Amsterdam, Netherlands)
DO  - 10.1080/01676830.2022.2087232
UR  - https://doi.org/10.1080/01676830.2022.2087232
ER  -

APA

JK, P., LC, H., & AL, K. (2023). Erdheim-Chester disease and vemurafenib: a review of ophthalmic presentations and clinical outcomes.. Orbit (Amsterdam, Netherlands). https://doi.org/10.1080/01676830.2022.2087232

Source records

pubmed · retrieved 2026-09-27T17:17:02.925Z
europe-pmc · retrieved 2026-09-27T17:17:02.941Z